Federated Hermes’s LifeMD LFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.3M Buy
2,747,655
+1,728,578
+170% +$7.63M 0.02% 652
2026
Q1
$3.68M Buy
1,019,077
+38,792
+4% +$134K 0.01% 856
2025
Q4
$3.34M Buy
980,285
+721,018
+278% +$3.5M 0.01% 860
2025
Q3
$1.76M Buy
259,267
+124,069
+92% +$1.02M ﹤0.01% 972
2025
Q2
$1.84M Buy
+135,198
New +$1.28M ﹤0.01% 962

Other funds holding LFMD

Federated Hermes's LFMD Position: Q2 2026 in Review

Federated Hermes increased its LifeMD (LFMD) stake by 170% in Q2 2026, buying an estimated $7.63M and bringing the position to 2,747,655 shares worth $11.3M. The position accounts for 0.02% of the portfolio, ranked #652.

Federated Hermes first reported a position in LFMD in Q2 2025 and has held it in 5 quarters since. 116 funds tracked by Wall St. Rank hold LFMD as of Q2 2026.

  • Federated Hermes held 2,747,655 shares of LifeMD worth $11.3M as of Q2 2026.
  • Federated Hermes bought 1,728,578 LifeMD shares in Q2 2026, an estimated $7.63M.
  • LifeMD made up 0.02% of Federated Hermes's portfolio in Q2 2026, its #652 holding.
  • Federated Hermes first reported a position in LifeMD in Q2 2025 and has held it in 5 quarters since.
  • 116 funds tracked by Wall St. Rank held LifeMD as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.